idiopathic pulmonary fibrosis

InterMune Gearing Up For Another Round With The FDA
Yahoo/Reuters
Thu, 11/29/12 - 12:03 pm
InterMune
FDA
IPF
idiopathic pulmonary fibrosis
pirfenidone
Drug Pricing Takes This Biotech on a Rollercoaster
Motley Fool
Sat, 03/17/12 - 10:38 am
InterMune
idiopathic pulmonary fibrosis
Esbriet
InterMune's Esbriet rings up $2.8 million in sales since mid-September launch in Germany
Yahoo/AP
Thu, 01/5/12 - 01:01 pm
Esbriet
InterMune
IPF
idiopathic pulmonary fibrosis
Germany
InterMune Shares Plunged: What You Need to Know
Motley Fool
Sat, 12/17/11 - 11:30 am
InterMune
idiopathic pulmonary fibrosis
ITMN's Esbriet Safe Long Term
Yahoo/Zacks
Sat, 10/1/11 - 12:45 pm
InterMune
Esbriet
idiopathic pulmonary fibrosis
Pirfenidone Phase 3 Results Published Today in The Lancet
Yahoo/PR NewsWire
Sat, 05/14/11 - 12:48 pm
pirfenidone
anti-inflammatory
antifibrotic
idiopathic pulmonary fibrosis
Gilead ends trial of lung disease drug candidate
Yahoo/AP
Thu, 12/23/10 - 08:34 am
Gilead Sciences
ambrisenten
IPF
idiopathic pulmonary fibrosis
Gilead to Buy Arresto Biosciences for $225 Million to Obtain Lung Medicine
Bloomberg
Mon, 12/20/10 - 12:29 pm
Arresto Biosciences
M&A
Gilead Sciences
IPF
idiopathic pulmonary fibrosis
InterMune surges on EU lung drug recommendation
Yahoo/AP
Sat, 12/18/10 - 12:18 pm
InterMune
Esbriet
idiopathic pulmonary fibrosis
The Next Biotech Drug to Watch: InterMune’s Pirfenidone
Minyanville
Sat, 05/1/10 - 10:23 am
InterMune
pirfenidone
idiopathic pulmonary fibrosis

Pages